Logo image of EVK

EVER-GLORY INTERNATIONAL GRO (EVK) Stock Fundamental Analysis

NASDAQ:EVK - Nasdaq - US2997662042 - Common Stock - Currency: USD

0.2944  -0.14 (-32.4%)

After market: 0.2896 0 (-1.63%)

Fundamental Rating

2

Overall EVK gets a fundamental rating of 2 out of 10. We evaluated EVK against 49 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of EVK is average, but there are quite some concerns on its profitability. EVK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

EVK had negative earnings in the past year.
EVK had a positive operating cash flow in the past year.
EVK Yearly Net Income VS EBIT VS OCF VS FCFEVK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M

1.2 Ratios

EVK has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
EVK Yearly ROA, ROE, ROICEVK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 5 10 15

1.3 Margins

EVK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EVK Yearly Profit, Operating, Gross MarginsEVK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 20 30

More info and screens

5

2. Health

2.1 Basic Checks

EVK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, EVK has about the same amount of shares outstanding.
Compared to 1 year ago, EVK has an improved debt to assets ratio.
EVK Yearly Shares OutstandingEVK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 5M 10M
EVK Yearly Total Debt VS Total AssetsEVK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

EVK has an Altman-Z score of 1.87. This is not the best score and indicates that EVK is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of EVK (1.87) is worse than 78.26% of its industry peers.
EVK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.87
ROIC/WACCN/A
WACC3.51%
EVK Yearly LT Debt VS Equity VS FCFEVK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 50M 100M

2.3 Liquidity

EVK has a Current Ratio of 1.24. This is a normal value and indicates that EVK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.24, EVK is doing worse than 91.30% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that EVK may have some problems paying its short term obligations.
EVK has a Quick ratio (0.96) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.96
EVK Yearly Current Assets VS Current LiabilitesEVK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

1

3. Growth

3.1 Past

EVK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -293.73%.
Looking at the last year, EVK shows a quite strong growth in Revenue. The Revenue has grown by 11.64% in the last year.
EVK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -3.36% yearly.
EPS 1Y (TTM)-293.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.36%
Revenue 1Y (TTM)11.64%
Revenue growth 3Y-9.63%
Revenue growth 5Y-3.36%
Sales Q2Q%12.74%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EVK Yearly Revenue VS EstimatesEVK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EVK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EVK Price Earnings VS Forward Price EarningsEVK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -5.34
EVK Per share dataEVK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EVK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVER-GLORY INTERNATIONAL GRO

NASDAQ:EVK (12/23/2022, 8:00:02 PM)

After market: 0.2896 0 (-1.63%)

0.2944

-0.14 (-32.4%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)N/A N/A
Earnings (Next)04-11 2023-04-11
Inst Owners1.24%
Inst Owner Change0%
Ins Owners34.08%
Ins Owner Change0%
Market Cap4.36M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 2.55
P/B 0.04
P/tB 0.04
EV/EBITDA -5.34
EPS(TTM)-0.19
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.12
OCFY39.18%
SpS22.96
BVpS7.91
TBVpS7.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 10.51
Cap/Depr 119.01%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.96
Altman-Z 1.87
F-Score5
WACC3.51%
ROIC/WACCN/A
Cap/Depr(3y)127.82%
Cap/Depr(5y)137.65%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-293.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-86.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.64%
Revenue growth 3Y-9.63%
Revenue growth 5Y-3.36%
Sales Q2Q%12.74%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-138.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-125.58%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-94.67%
OCF growth 3YN/A
OCF growth 5YN/A